2nd November 2016 BSBMT Education Day


Presentations now available with permissions. More to follow..

Session 1

– Introduction: classifying and staging GVHD – Dr Rafael Duarte, Puerto De Hierro Hospital, Madrid

Modern management of acute and chronic skin GVHDDr Rubeta Matin, Oxford University Hospitals

– Mesenchymal stem cells in GVHD – Prof Katrina Le Blanc, Karolinska Institute, Stockholm

ECP in GVHD Dr Peter Taylor, The Rotherham Foundation NHS Trust

New agents in chronic GVHD; myth or fictionDr Paul Martin, Fred Hutchinson Cancer Research Centre Seattle, USA

Session 2: BSBMT Open Meeting

President’s ReportDr Charles Crawley
CTC Report – Andy Peniket
Treasurer’s Report – Dr Fiona Dignan
Data Registry ReportMrs Julia Perry
JACIE Report Dr Kim Orchard

Session 3

Symptom control and supportive care in BMT Prof Sam Ahmedzai, University of Sheffied

– HSCT as a cause of and therapy for neurological diseases – Prof John Snowden, Sheffield Teaching Hospitals

– HSCT in management of primary CNS lymphoma – Dr Stephen Robinson, University Hospitals Bristol

Session 4: BSBMT Clinical Trials update

– UK Haplo studies – Dr Kavita Raj, King’s College Hospital

– AZTEC: Azacitidine and cGVHD- Dr Ram Malladi, University Hospitals Birmingham

– Trials for multiple sclerosis- Prof John Snowden, Sheffield Teaching Hospitals

– The CTC, IMPACT and future UK transplant studies- Dr Andy Peniket, Oxford University Hospitals